To investigate the impact of maintaining a balance between GSDMD-mediated cell damage and CHMP4B-dependent cell repair on kidney stone formation, we increased the expression of CHMP4B levels through tail vein injection of adeno-associated virus while reducing pyroptosis by intraperitoneal injection of a GSDMD inhibitor. The gene discussed is CHMP4B; the disease is nephrolithiasis.